Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma-Reference-Cited by-同舟云学术

Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma

Published:2019-12-27 Issue:4 Volume:9 Page:1392-1399
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chen Zhongqing¹^ORCID,Wang Ying¹,Fang Min¹

Affiliation:

1. Department of Clinical Laboratory Guangxi Medical University Cancer Hospital Nanning Guangxi People’s Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2809

Reference43 articles.

1. Switching off malignant pleural effusion formation‐fantasy or future?;Spella M;J Thorac Dis,2015

2. Targeting Vascular Endothelial Growth Factor Blockade: Ascites and Pleural Effusion Formation

3. Mast cells mediate malignant pleural effusion formation

4. Mutant KRAS promotes malignant pleural effusion formation

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical value of combined detection of Carcinoembryonic Antigen and CA125 in the diagnosis of non-small cell lung cancer combined with Malignant Pleural Effusion;Pakistan Journal of Medical Sciences;2024-03-18

2. Diagnostic value of combined detection of plasma cfDNA concentration and integrity in NSCLC;Lung Cancer Management;2024-02-28

3. Prognostic value of the ratio of pretreatment carcinoembryonic antigen to tumor volume in rectal cancer;Journal of Gastrointestinal Oncology;2023-12

4. High-precision bladder cancer diagnosis method: 2D Raman spectrum figures based on maintenance technology combined with automatic weighted feature fusion network;Analytica Chimica Acta;2023-11

5. Update value and clinical application of MUC16 (cancer antigen 125);Expert Opinion on Therapeutic Targets;2023-08-03